Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

Articles published in
Ann Surg Oncol
    May 2018
  1. NARAYANAN S, Kawaguchi T, Yan L, Peng X, et al
    Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
    Ann Surg Oncol. 2018 May 16. pii: 10.1245/s10434-018-6506.
    >> Share

  2. VAN DEN BROEK J, Geenen R, Heijnen L, Kobus C, et al
    Adrenal Incidentalomas During Diagnostic Work-up of Colorectal Cancer Patients: What is the Risk of Metastases?
    Ann Surg Oncol. 2018 May 14. pii: 10.1245/s10434-018-6501.
    >> Share

  3. JACOBSON R, Sherman SK, Dadaleh F, Turaga KK, et al
    Peritoneal Metastases in Colorectal Cancer.
    Ann Surg Oncol. 2018 May 10. pii: 10.1245/s10434-018-6490.
    >> Share

    April 2018
  4. BABCOCK BD, Aljehani MA, Jabo B, Choi AH, et al
    High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
    Ann Surg Oncol. 2018 Apr 19. pii: 10.1245/s10434-018-6484.
    >> Share

  5. WEISER MR
    AJCC 8th Edition: Colorectal Cancer.
    Ann Surg Oncol. 2018 Apr 3. pii: 10.1245/s10434-018-6462.
    >> Share

    March 2018
  6. SHIDA D, Yoshida T, Tanabe T, Tsukamoto S, et al
    Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis.
    Ann Surg Oncol. 2018 Mar 23. pii: 10.1245/s10434-018-6436.
    >> Share

  7. SIMONEAU E, Vauthey JN
    Progression of Colorectal Cancer Liver Metastasis After Chemotherapy: A New Test of Time?
    Ann Surg Oncol. 2018 Mar 19. pii: 10.1245/s10434-018-6439.
    >> Share

  8. FLAHERTY DC, Jalas JR, Sim MS, Stojadinovic A, et al
    The Negative Impact of Body Mass Index on the Tumor Microenvironment in Colon Cancer: Results of a Prospective Trial.
    Ann Surg Oncol. 2018 Mar 12. pii: 10.1245/s10434-018-6405.
    >> Share

  9. NAGATA H, Ishihara S, Oba K, Tanaka T, et al
    Development and Validation of a Prediction Model for Postoperative Peritoneal Metastasis After Curative Resection of Colon Cancer.
    Ann Surg Oncol. 2018 Mar 5. pii: 10.1245/s10434-018-6403.
    >> Share

    February 2018
  10. HOPKINS JJ, Skubleny D, Bigam DL, Baracos VE, et al
    Barriers to the Interpretation of Body Composition in Colorectal Cancer: A Review of the Methodological Inconsistency and Complexity of the CT-Defined Body Habitus.
    Ann Surg Oncol. 2018 Feb 27. pii: 10.1245/s10434-018-6395.
    >> Share

    December 2017
  11. TAKAHASHI G, Yamada T, Iwai T, Takeda K, et al
    Oncological Assessment of Stent Placement for Obstructive Colorectal Cancer from Circulating Cell-Free DNA and Circulating Tumor DNA Dynamics.
    Ann Surg Oncol. 2017 Dec 12. pii: 10.1245/s10434-017-6300.
    >> Share

    November 2017
  12. CREASY JM, Sadot E, Koerkamp BG, Chou JF, et al
    The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.
    Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6264.
    >> Share

  13. DURAES LC, Stocchi L, Steele SR, Kalady MF, et al
    The Relationship Between Clavien-Dindo Morbidity Classification and Oncologic Outcomes After Colorectal Cancer Resection.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6142.
    >> Share

    October 2017
  14. TIERNAN JP, Jayne DG
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis.
    Ann Surg Oncol. 2017 Oct 31. doi: 10.1245/s10434-017-6200.
    >> Share

  15. OH BY, Park YA, Huh JW, Yun SH, et al
    Prognostic Impact of Tumor-Budding Grade in Stages 1-3 Colon Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6135.
    >> Share

  16. POVOSKI SP, Hatzaras IS, Mojzisik CM, Arnold MW, et al
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis: A Reply.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6201.
    >> Share

  17. WATANABE K, Salah S, Saito N
    Comment on: Risk Factors for Survival After Lung Metastasectomy for Colorectal Cancer Patients.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6199.
    >> Share

  18. BINAY SAFER V, Safer U, Yorulmaz E, Sahin Z, et al
    Comment: Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6166.
    >> Share

  19. KLAVER CEL, van Huijgevoort NCM, de Buck van Overstraeten A, Wolthuis AM, et al
    Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases.
    Ann Surg Oncol. 2017 Oct 26. doi: 10.1245/s10434-017-6037.
    >> Share

  20. PASSOT G, Kim BJ, Glehen O, Mehran RJ, et al
    Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
    Ann Surg Oncol. 2017 Oct 25. doi: 10.1245/s10434-017-6141.
    >> Share

  21. SHIDA D, Tsukamoto S, Ochiai H, Kanemitsu Y, et al
    Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2017 Oct 23. doi: 10.1245/s10434-017-6133.
    >> Share

    September 2017
  22. CLARKE CN, Lee MS, Wei W, Manyam G, et al
    Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
    Ann Surg Oncol. 2017 Sep 21. doi: 10.1245/s10434-017-6054.
    >> Share

  23. DEMEY K, Wolthuis A, de Buck van Overstraeten A, Fieuws S, et al
    External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal Cancer.
    Ann Surg Oncol. 2017 Sep 11. doi: 10.1245/s10434-017-6042.
    >> Share

  24. MATSUDA T, Sumi Y, Yamashita K, Hasegawa H, et al
    Anatomy of the Transverse Mesocolon Based on Embryology for Laparoscopic Complete Mesocolic Excision of Right-Sided Colon Cancer.
    Ann Surg Oncol. 2017 Sep 5. doi: 10.1245/s10434-017-6070.
    >> Share

    August 2017
  25. LORIMER PD, Motz BM, Kirks RC, Boselli DM, et al
    Pathologic Complete Response Rates After Neoadjuvant Treatment in Rectal Cancer: An Analysis of the National Cancer Database.
    Ann Surg Oncol. 2017;24:2095-2103.
    >> Share

  26. WHEALON MD, Gahagan JV, Sujatha-Bhaskar S, O'Leary MP, et al
    Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
    Ann Surg Oncol. 2017;24:2122-2128.
    >> Share

  27. SCHNEIDER MA, Eshmuminov D, Lehmann K
    Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC.
    Ann Surg Oncol. 2017;24:2224-2232.
    >> Share

  28. SEEBERG LT, Brunborg C, Waage A, Hugenschmidt H, et al
    Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2017;24:2113-2121.
    >> Share

    July 2017
  29. WATT DG, Ramanathan ML, McSorley ST, Walley K, et al
    Clinicopathological Determinants of an Elevated Systemic Inflammatory Response Following Elective Potentially Curative Resection for Colorectal Cancer.
    Ann Surg Oncol. 2017 Jul 10. doi: 10.1245/s10434-017-5987.
    >> Share

    June 2017
  30. HA GW, Kim JH, Lee MR
    Oncologic Impact of Anastomotic Leakage Following Colorectal Cancer Surgery: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2017 Jun 12. doi: 10.1245/s10434-017-5881.
    >> Share

  31. YAMASHITA S, Sakamoto Y, Yamamoto S, Takemura N, et al
    Efficacy of Preoperative Portal Vein Embolization Among Patients with Hepatocellular Carcinoma, Biliary Tract Cancer, and Colorectal Liver Metastases: A Comparative Study Based on Single-Center Experience of 319 Cases.
    Ann Surg Oncol. 2017;24:1557-1568.
    >> Share

  32. LIM TZ, Chan DKH, Tan KK
    Endoscopic Stenting Does Not Worsen Long Term Outcomes Amongst Patients Presenting with Obstruction from Colorectal Cancers.
    Ann Surg Oncol. 2017;24:1618-1625.
    >> Share

    May 2017
  33. D'ANGELICA MI
    Positive Margins After Resection of Metastatic Colorectal Cancer in the Liver: Back to the Drawing Board?
    Ann Surg Oncol. 2017 May 31. doi: 10.1245/s10434-017-5908.
    >> Share

  34. SIMPSON AL, Doussot A, Creasy JM, Adams LB, et al
    Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2017 May 30. doi: 10.1245/s10434-017-5896.
    >> Share

  35. YOU YN, Shiozaki H, Lee JE, Passot G, et al
    Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection.
    Ann Surg Oncol. 2017 May 16. doi: 10.1245/s10434-017-5878.
    >> Share

  36. HAWKINS AT, Wells KO, Krishnamurty DM, Hunt SR, et al
    Preoperative Chemotherapy and Survival for Large Anorectal Gastrointestinal Stromal Tumors: A National Analysis of 333 Cases.
    Ann Surg Oncol. 2017;24:1195-1201.
    >> Share

  37. ACHARYA A, Markar SR, Matar M, Ni M, et al
    Use of Tumor Markers in Gastrointestinal Cancers: Surgeon Perceptions and Cost-Benefit Trade-Off Analysis.
    Ann Surg Oncol. 2017;24:1165-1173.
    >> Share

  38. VYCHNEVSKAIA K, Dumont F, Agostini J, Julie C, et al
    Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer.
    Ann Surg Oncol. 2017;24:1304-1311.
    >> Share

  39. YAMASHITA S, Loyer E, Kang HC, Aloia TA, et al
    Total Transthoracic Approach Facilitates Laparoscopic Hepatic Resection in Patients with Significant Prior Abdominal Surgery.
    Ann Surg Oncol. 2017;24:1376-1377.
    >> Share

  40. DREYER SB, Powell AG, McSorley ST, Waterston A, et al
    The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer.
    Ann Surg Oncol. 2017;24:1295-1303.
    >> Share

  41. KULAYLAT AS, Hollenbeak CS, Stewart DB Sr
    Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status.
    Ann Surg Oncol. 2017;24:1281-1288.
    >> Share

    April 2017
  42. CHOULIARAS K, Levine EA, Fino N, Shen P, et al
    Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC).
    Ann Surg Oncol. 2017;24:890-897.
    >> Share

  43. DHIR M, Ramalingam L, Shuai Y, Pakrafter S, et al
    Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases.
    Ann Surg Oncol. 2017;24:875-883.
    >> Share

  44. CHAN CH, Liesenfeld LF, Ferreiro-Neira I, Cusack JC Jr, et al
    Preclinical Evaluation of Cathepsin-Based Fluorescent Imaging System for Cytoreductive Surgery.
    Ann Surg Oncol. 2017;24:931-938.
    >> Share

  45. MEHTA AM, Huitema AD, Burger JW, Brandt-Kerkhof AR, et al
    Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution.
    Ann Surg Oncol. 2017;24:990-997.
    >> Share

  46. IHEMELANDU C
    Inflammation-Based Prognostic Scores: Utility in Prognostication and Patient Selection for Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Metastasis of Colonic Origin.
    Ann Surg Oncol. 2017;24:884-889.
    >> Share

  47. IHEMELANDU C, Sugarbaker PH
    Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades.
    Ann Surg Oncol. 2017;24:898-905.
    >> Share

  48. WRIGHT GP, Marsh JW, Varma MK, Doherty MG, et al
    Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
    Ann Surg Oncol. 2017;24:906-913.
    >> Share

  49. VIGANO L, Lopci E, Costa G, Rodari M, et al
    Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
    Ann Surg Oncol. 2017;24:1029-1036.
    >> Share

  50. MACHADO MA, Surjan R, Basseres T, Makdissi F, et al
    Total Laparoscopic Reversal ALPPS.
    Ann Surg Oncol. 2017;24:1048-1049.
    >> Share

    March 2017
  51. MCSORLEY ST, Roxburgh CS, Horgan PG, McMillan DC, et al
    The Impact of Preoperative Dexamethasone on the Magnitude of the Postoperative Systemic Inflammatory Response and Complications Following Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2017 Mar 1. doi: 10.1245/s10434-017-5817.
    >> Share

  52. WAITE K, Youssef H
    The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review.
    Ann Surg Oncol. 2017;24:705-720.
    >> Share

  53. THORGERSEN EB, Goscinski MA, Spasojevic M, Solbakken AM, et al
    Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2017;24:721-728.
    >> Share

    February 2017
  54. ALI SM, Pawlik TM, Rodriguez-Bigas MA, Monson JR, et al
    Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis.
    Ann Surg Oncol. 2017 Feb 21. doi: 10.1245/s10434-016-5745.
    >> Share

  55. CAVNAR MJ, Turcotte S, Katz SC, Kuk D, et al
    Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome.
    Ann Surg Oncol. 2017 Feb 17. doi: 10.1245/s10434-017-5812.
    >> Share

  56. LEE DY, Teng A, Pedersen RC, Tavangari FR, et al
    Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer.
    Ann Surg Oncol. 2017;24:311-318.
    >> Share

  57. CHOI SH, Choi GH, Han DH, Kwon SW, et al
    Laparoscopic Right Hepatectomy: Toward Protocolization and Simplification.
    Ann Surg Oncol. 2017;24:554-555.
    >> Share

    January 2017
  58. ALOTAIBI AM, Lee JL, Kim J, Lim SB, et al
    Prognostic and Oncologic Significance of Perineural Invasion in Sporadic Colorectal Cancer.
    Ann Surg Oncol. 2017 Jan 9. doi: 10.1245/s10434-016-5748.
    >> Share

  59. SIOULAS VD, Jorge S, Chern JY, Schiavone MB, et al
    Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy.
    Ann Surg Oncol. 2017;24:251-256.
    >> Share

  60. WIMMER K, Schwarz C, Szabo C, Bodingbauer M, et al
    Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2017;24:236-243.
    >> Share

  61. BEPPU N, Kimura F, Aihara T, Doi H, et al
    Patterns of Local Recurrence and Oncologic Outcomes in T3 Low Rectal Cancer (</=5 cm from the Anal Verge) Treated With Short-Course Radiotherapy With Delayed Surgery : Outcomes in T3 Low Rectal Cancer Treated With Short-Course Radiotherapy With Del
    Ann Surg Oncol. 2017;24:219-226.
    >> Share

  62. MARGONIS GA, Sasaki K, Andreatos N, Kim Y, et al
    KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2017;24:264-271.
    >> Share

  63. DHIR M, Jones HL, Shuai Y, Clifford AK, et al
    Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case-Control Study.
    Ann Surg Oncol. 2017;24:150-158.
    >> Share

  64. ORCUTT ST, Massarweh NN, Li LT, Artinyan A, et al
    Patterns of Care for Colorectal Liver Metastasis Within an Integrated Health System: Secular Trends and Outcomes.
    Ann Surg Oncol. 2017;24:23-30.
    >> Share

    December 2016
  65. XIE D, Yu C, Gao C, Osaiweran H, et al
    An Optimal Approach for Laparoscopic D3 Lymphadenectomy Plus Complete Mesocolic Excision (D3+CME) for Right-Sided Colon Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  66. NAGATA H, Ishihara S, Hata K, Murono K, et al
    Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer.
    Ann Surg Oncol. 2016.
    >> Share

    November 2016
  67. KIM JE, Hong YS, Kim HJ, Kim KP, et al
    Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
    Ann Surg Oncol. 2016.
    >> Share

  68. KITAHARA T, Haraguchi N, Takahashi H, Nishimura J, et al
    Identification and Characterization of CD107a as a Marker of Low Reactive Oxygen Species in Chemoresistant Cells in Colorectal Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  69. WATT DG, McSorley ST, Park JH, Horgan PG, et al
    A Postoperative Systemic Inflammation Score Predicts Short- and Long-Term Outcomes in Patients Undergoing Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  70. LISKA D, Stocchi L, Karagkounis G, Elagili F, et al
    Incidence, Patterns, and Predictors of Locoregional Recurrence in Colon Cancer.
    Ann Surg Oncol. 2016.
    >> Share

    October 2016
  71. KIM TJ, Kim ER, Hong SN, Kim YH, et al
    Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome.
    Ann Surg Oncol. 2016.
    >> Share

  72. BECERRA AZ, Aquina CT, Mohile SG, Tejani MA, et al
    Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients.
    Ann Surg Oncol. 2016.
    >> Share

  73. VAN DE GRAAF FW, Lange MM, Menon AG, O'Mahoney PR, et al
    Erratum to: Imaging for Quality Control: Comparison of Systematic Video Recording to the Operative Note in Colorectal Cancer Surgery. A Pilot Study.
    Ann Surg Oncol. 2016.
    >> Share

  74. KIM CG, Ahn JB, Jung M, Beom SH, et al
    Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
    Ann Surg Oncol. 2016.
    >> Share

    September 2016
  75. VAN DEGRAAF FW, Lange MM, Menon AG, O'Mahoney PR, et al
    Imaging for Quality Control: Comparison of Systematic Video Recording to the Operative Note in Colorectal Cancer Surgery. A Pilot Study.
    Ann Surg Oncol. 2016.
    >> Share

  76. NAVEZ J, Remue C, Leonard D, Bachmann R, et al
    Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience.
    Ann Surg Oncol. 2016.
    >> Share

  77. KATAOKA M, Kanda M, Ishigure K, Matsuoka H, et al
    Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  78. CIENFUEGOS JA, Martinez P, Baixauli J, Beorlegui C, et al
    Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  79. BECERRA AZ, Berho ME, Probst CP, Aquina CT, et al
    Variation in Hospital-Specific Rates of Suboptimal Lymphadenectomy and Survival in Colon Cancer: Evidence from the National Cancer Data Base.
    Ann Surg Oncol. 2016.
    >> Share

  80. KATAOKA M, Kanda M, Ishigure K, Matsuoka H, et al
    The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.
    Ann Surg Oncol. 2016.
    >> Share

    August 2016
  81. BARATTI D, Kusamura S, Iusco D, Gimondi S, et al
    Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases.
    Ann Surg Oncol. 2016.
    >> Share

  82. TAN CN, Chong CS, Fong YF, Rauff S, et al
    Laparoscopic Anterior Resection with Transvaginal Specimen Extraction (TVSE) for Colorectal Cancer and Concomitant Total Hysterectomy and Bilateral Salpingo-Oophrectomy (THBSO): A Technical Description.
    Ann Surg Oncol. 2016.
    >> Share

    July 2016
  83. NISHIZAWA Y, Nishida N, Konno M, Kawamoto K, et al
    Clinical Significance of Histone Demethylase NO66 in Invasive Colorectal Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  84. DURAES LC, Stocchi L, Dietz D, Kalady MF, et al
    The Disproportionate Effect of Perioperative Complications on Mortality within 1 Year After Colorectal Cancer Resection in Octogenarians.
    Ann Surg Oncol. 2016.
    >> Share

  85. KARANICOLAS PJ, Ko YJ
    Hepatic Arterial Infusion for Unresectable Liver Metastases from Colorectal Cancer: The Dawn of a New Era?
    Ann Surg Oncol. 2016.
    >> Share

  86. LAO X, Feng Q, He G, Ji M, et al
    Immature Colon Carcinoma Transcript-1 (ICT1) Expression Correlates with Unfavorable Prognosis and Survival in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  87. AMRI R, England J, Bordeianou LG, Berger DL, et al
    Risk Stratification in Patients with Stage II Colon Cancer.
    Ann Surg Oncol. 2016.
    >> Share

    June 2016
  88. YAMAMOTO H, Maeda K, Arima H, Sonoda H, et al
    Perioperative Adiponectin Measurement is Useful for Prediction of Postoperative Infection in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  89. CHEMAMA S, Bayar MA, Lanoy E, Ammari S, et al
    Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  90. SHIDA D, Hamaguchi T, Ochiai H, Tsukamoto S, et al
    Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis.
    Ann Surg Oncol. 2016.
    >> Share

  91. SUGIMACHI K, Matsumura T, Shimamura T, Hirata H, et al
    Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  92. PATEL D, Townsend AR, Karapetis C, Beeke C, et al
    Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry.
    Ann Surg Oncol. 2016.
    >> Share

    May 2016
  93. LIM C, Doussot A, Osseis M, Salloum C, et al
    Primary Tumor Versus Liver-First Strategy in Patients with Stage IVA Colorectal Cancer: A Propensity Score Analysis of Long-term Outcomes and Recurrence Pattern.
    Ann Surg Oncol. 2016.
    >> Share

  94. TARANTINO I, Huttner FJ, Warschkow R, Schmied BM, et al
    Prognostic Relevance of Mucinous Subtype in a Population-based Propensity Score Analysis of 40,083 Rectal Cancer Patients.
    Ann Surg Oncol. 2016;23:1576-86.
    >> Share

  95. COLOMBO PE, Bertrand MM, Alline M, Boulay E, et al
    Robotic Versus Laparoscopic Total Mesorectal Excision (TME) for Sphincter-Saving Surgery: Is There Any Difference in the Transanal TME Rectal Approach? : A Single-Center Series of 120 Consecutive Patients.
    Ann Surg Oncol. 2016;23:1594-600.
    >> Share

    March 2016
  96. LEE SJ, Kang BW, Chae YS, Kim HJ, et al
    Pilot Study of Neoadjuvant Chemoradiotherapy with Three Cycles of 5-Fluorouracil Plus Leucovorin for Treatment of Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2016;23:894-9.
    >> Share

  97. ROBINSON C, Artinyan A
    Pushing the Limits of Local Excision for Rectal Cancer: Transanal Minimally Invasive Surgery (TAMIS) for Rectal Cancer Using the Port-in-Port Technique.
    Ann Surg Oncol. 2016;23:918.
    >> Share

  98. HUNTINGTON CR, Boselli D, Symanowski J, Hill JS, et al
    Optimal Timing of Surgical Resection After Radiation in Locally Advanced Rectal Adenocarcinoma: An Analysis of the National Cancer Database.
    Ann Surg Oncol. 2016;23:877-87.
    >> Share

  99. ZIMMITTI G, Soliz J, Aloia TA, Gottumukkala V, et al
    Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2016;23:1003-11.
    >> Share

  100. LUDMIR EB, Arya R, Wu Y, Palta M, et al
    Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era.
    Ann Surg Oncol. 2016;23:856-62.
    >> Share

  101. MAILLET M, Glehen O, Lambert J, Goere D, et al
    Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study.
    Ann Surg Oncol. 2016;23:863-9.
    >> Share

  102. CHANG SC, Lin PC, Lin JK, Lin CH, et al
    Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.
    Ann Surg Oncol. 2016;23:849-55.
    >> Share

  103. LEOWARDI C, Schneider ML, Hinz U, Harnoss JM, et al
    Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.
    Ann Surg Oncol. 2016;23:870-6.
    >> Share

  104. SIMKENS GA, van Oudheusden TR, Luyer MD, Nienhuijs SW, et al
    Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis.
    Ann Surg Oncol. 2016;23:833-41.
    >> Share

    February 2016
  105. MATSUMOTO Y, Tsujimoto H, Ono S, Shinomiya N, et al
    Abdominal Infection Suppresses the Number and Activity of Intrahepatic Natural Killer Cells and Promotes Tumor Growth in a Murine Liver Metastasis Model.
    Ann Surg Oncol. 2016;23 Suppl 2:S257-65.
    >> Share

  106. MAEDA Y, Shinohara T, Nagatsu A, Futakawa N, et al
    Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2016;23 Suppl 2:S242-8.
    >> Share

  107. KOYAMA M, Murata A, Sakamoto Y, Morohashi H, et al
    Risk Factors for Anastomotic Leakage After Intersphincteric Resection Without a Protective Defunctioning Stoma for Lower Rectal Cancer.
    Ann Surg Oncol. 2016;23 Suppl 2:S249-56.
    >> Share

  108. KENG C, Coates A, Grubac V, Lovrics P, et al
    The Need for Consensus and Transparency in Assessing Population-Based Rates of Positive Circumferential Radial Margins in Rectal Cancer: Data from Consecutive Cases in a Large Region of Ontario, Canada.
    Ann Surg Oncol. 2016;23:397-402.
    >> Share

  109. YAMAMOTO H, Tomita N, Inomata M, Furuhata T, et al
    OSNA-Assisted Molecular Staging in Colorectal Cancer: A Prospective Multicenter Trial in Japan.
    Ann Surg Oncol. 2016;23:391-6.
    >> Share

  110. TOKUNAGA R, Sakamoto Y, Nakagawa S, Miyake K, et al
    The Prognostic Significance of Histone Lysine Demethylase JMJD3/KDM6B in Colorectal Cancer.
    Ann Surg Oncol. 2016;23:678-85.
    >> Share

  111. DOWNS-CANNER S, Magge D, Ravindranathan R, O'Malley ME, et al
    Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer.
    Ann Surg Oncol. 2016;23:655-62.
    >> Share

  112. NISHIGORI N, Koyama F, Nakagawa T, Nakamura S, et al
    Visualization of Lymph/Blood Flow in Laparoscopic Colorectal Cancer Surgery by ICG Fluorescence Imaging (Lap-IGFI).
    Ann Surg Oncol. 2016;23 Suppl 2:S266-74.
    >> Share

  113. YAMADA T, Okabayashi K, Hasegawa H, Tsuruta M, et al
    Age, Preoperative Subcutaneous Fat Area, and Open Laparotomy are Risk Factors for Incisional Hernia following Colorectal Cancer Surgery.
    Ann Surg Oncol. 2016;23 Suppl 2:S236-41.
    >> Share

    January 2016
  114. WEISER MR
    Rectal Cancer: Time for Precision Medicine?
    Ann Surg Oncol. 2016;23:12-5.
    >> Share

  115. KULU Y, Tarantino I, Billeter AT, Diener MK, et al
    Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Ann Surg Oncol. 2016;23:106-13.
    >> Share

  116. SIMKENS GA, van Oudheusden TR, Braam HJ, Luyer MD, et al
    Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters.
    Ann Surg Oncol. 2016;23:99-105.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016